Adult-onset neuronal ceroid lipofuscinosis misdiagnosed as autoimmune encephalitis and normal-pressure hydrocephalus: A 10-year case report and case-based review.

Liming Cao, Yanni Yu, Huasheng Huang, Yuqi Liao, HuiHui Qin, Yi Zhi Wei

Journal: Medicine 2024;103(43):e40248

PMID: 39470529

Abstract

RATIONALE

Neuronal ceroid lipofuscinoses (NCLs) are rare, fatal, inherited neurodegenerative disorders characterized by myoclonic epilepsy, cognitive decline, brain atrophy, and retinopathy. The pathogenesis and clinical manifestations of NCL are not well understood and frequently result in misdiagnosis and overtreatment. The aim of this case report and review is to improve our understanding of the clinical features and management of NCL.

PATIENT CONCERNS

A 36-year-old woman initially presented with refractory epilepsy.

DIAGNOSES

Initially diagnosed with autoimmune encephalitis, the patient was later diagnosed with normal-pressure hydrocephalus. A definitive diagnosis of adult-onset neuronal ceroid lipofuscinosis (ANCL) was established after 10 years of observation, utilizing biopsy and genetic testing.

INTERVENTIONS

High-dose intravenous immunoglobulin and methylprednisolone were administered, along with the insertion of a ventriculoperitoneal shunt.

OUTCOMES

Despite various treatments, the patient's condition did not improve.

LESSONS

ANCL typically presents with the clinical triad of refractory seizures, progressive cognitive decline, and movement disorders. Neuroimaging often reveals progressive brain atrophy on magnetic resonance imaging, while electroencephalograms frequently show epileptiform discharges. The prognosis is generally poor. Improved understanding of ANCL from both clinical and radiological perspectives, coupled with early consideration of differential diagnoses, could minimize unnecessary interventions and optimize patient care.

Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.

Address: Department of Neurology, Liuzhou People's Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China.; School of Medicine, Shenzhen University, Shenzhen, Guangdong Province, China.; Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.; Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.; Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, Hunan Province, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.